Compare Eni SpA (E) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eni SpA vs Tilray Brands Inc — how do they compare? Eni SpA trades at $48.17 (market cap $70.34B), while Tilray Brands Inc trades at $4.34 (market cap $541.36M). The key difference: Eni SpA is far larger — about 129.9× Tilray Brands Inc's market cap, and Eni SpA pays a 4.99% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| E | TLRY | |
|---|---|---|
Market Cap | $70.34B | $541.36M |
Sector | Energy | Health |
52-Week High | $57.61 | $21.00 |
52-Week Low | $32.93 | $4.31 |
Enterprise Value | $89.25B | $638.50M |
Dividend Yield | 4.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $48.11, down 2.91% over 24 hours, with a bullish technical signal supported by moving averages but mixed oscillators. The company shows stable cash flow generation with $238 million net cash flow in 2025, though revenue has declined from $132.5B in 2022 to $82.2B in 2025. Recent strategic moves include expanding into lithium, battery storage, and fusion energy partnerships, signaling diversification beyond traditional oil and gas.
The outlook balances diversification efforts against revenue pressures; the stock's low P/S of 0.79 and EV/EBITDA of 3.83 suggest undervaluation, but investors face risks from oil price volatility and execution challenges in new ventures. Analyst consensus is cautious with 61.53% hold ratings, reflecting uncertainty amid transition initiatives.
TLRY trades at $4.36, down 0.57% on the day, amid a bearish technical signal and mixed quarterly earnings. The company reported a net loss of -$2.19 billion for 2025 despite revenue growth to $821 million, with a negative net income margin of -156.67%. Recent developments include medical cannabis expansion in Panama and the acquisition of HelloMD to enhance digital healthcare capabilities.
While low valuation ratios (P/S of 0.55, P/B of 0.35) suggest potential undervaluation, persistent losses and negative cash flow from operations pose significant risks. Analyst sentiment is cautious with a 'Hold' consensus, reflecting concerns over profitability despite growth initiatives. The stock's outlook hinges on achieving sustainable profitability and navigating competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
